
Millie Das, MD, discusses first-line standards of care for patients with extensive-stage and limited-stage small cell lung cancer.

Your AI-Trained Oncology Knowledge Connection!


Millie Das, MD, is a clinical professor of medicine – oncology in the Department of Medicine at Stanford University; a member of the Stanford Cancer Institute; and chief of Oncology at the VA Palo Alto Health Care System

Millie Das, MD, discusses first-line standards of care for patients with extensive-stage and limited-stage small cell lung cancer.

Millie Das, MD, discusses key trials that have advanced treatment for patients who present with non–small cell lung cancer.

Millie Das, MD, of Stanford Cancer Center, discusses the progress in small cell lung cancer treatment.

Millie Das, MD, discusses the current landscape of new and emerging ADCs under investigation in small-cell lung cancer and highlights the phase 2 SWOG S1929 study.

Published: July 26th 2025 | Updated:

Published: May 15th 2024 | Updated: